The role of p14ARF methylation in neuroblastoma minimal residual disease

Erbayraktar Z., Zadeoglulari Z., AKTAŞ S., ELLİDOKUZ H., Kirkali G., Olgun N.

TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, vol.37, no.2, pp.129-138, 2012 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 37 Issue: 2
  • Publication Date: 2012
  • Doi Number: 10.5505/tjb.2012.57966
  • Journal Name: TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.129-138
  • Keywords: Neuroblastoma, p14(ARF) gene, DNA methylation, minimal residual disease, MYELOABLATIVE THERAPY, 13-CIS-RETINOIC ACID, CELL CARCINOMA, TUMOR, TEMOZOLOMIDE, PATHWAY, ARREST, GENE, MYC
  • Dokuz Eylül University Affiliated: Yes

Abstract

Objectives: The aim of the present study is to investigate the clinical significance of epigenetic changes in neuroblastoma, we evaluated the relationship between therapeutic variables and the pattern of gene methylation in neuroblastoma cell lines.